Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 3, 2010, Pages 418-422

  D'Armini, Andrea Maria ^a,b   Totaro, Pasquale ^a   Nicolardi, Salvatore ^b   Morsolini, Marco ^b   Silvaggio, Giuseppe ^a   Toscano, Francesca ^c   Toscano, Michele ^c   Viganò, Mario ^a,b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiphospholipid syndrome; Cerebral protection; Pulmonary endarterectomy

Indexed keywords

IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY TITER; CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENDARTERECTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ENDARTERECTOMY; SCREENING; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; ENDARTERECTOMY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOGLOBULIN G; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 77649297824     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.221630     Document Type: Conference Paper

References (22)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.
2. Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J 1983;287:1088-1089.
3. Sanna G, Bertolaccini ML, Hughes GR. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology. Ann NY Acad Sci 2005; 1051:465-486.
4. Muscal E, Brey RL. Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine. Int J Clin Pract 2007;61:1561-1568.
5. Dafer RM, Biller J. Antiphospholipid syndrome: role of antiphospholipid antibodies in neurology. Hematol Oncol Clin North Am 2008;22:95-105.
6. Miesbach W. Neurologic symtoms as a feature of the antiphospholipid syndrome. Semin Thromb Hemost 2008;34:286-289.
7. Martino D, Chew NK, Mir P, Edwards M, Quinn NP, Bathia H. Atypical movement disorders in antiphospholipid syndrome. Mov Disord 2006; 21:944-949.
8. Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA, Shoenfeld Y. Non-stroke neurological syndrome associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus 2003;12:514-517.
9. Finazzi G, Brancaccio V, Moia M, Caivarella N, Mazzucconi G, Schinco P, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D'Angelo A, Palareti G, De Stefano V, Berrettini M, Barbui T. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med 1996;100:530-536.
10. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, Stevens P, Hirsh J. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685-3691.
11. Colorio CC, Martinuzzo ME, Forastiero RR, Pombo G, Adamczuk Y, Carreras LO. Thrombophilic factors in chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 2001;12:427-432.
12. Martinuzzo M, Pombo G, Forestiero R, Cerrato G, Colorio C, Carreras L. Lupus anticoagulant, high levels of anticardiolipin, and anti-b - 2 glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension. J Rheumatol 1998;25:1313-1319.
13. Porres-Aguilar M, Pena-Ruiz MA, Burgos J, Porres-Munoz M, Hughes HW. Chronic thromboembolic pulmonary hypertension as an uncommon presentation of primary antiphospholipid syndrome. J Natl Med Assoc 2008;100:734-736.
14. Nakajima T, Ando H, Ueno Y, Umadome H, Takahashi Y, Okano Y, Takamoto S. Successful thromboendarterectomy for chronic pulmonary embolism in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Jpn Circ J 1997;61:958-964.
15. D'Armini AM, Cattadori B, Monterosso C, Klersy C, Emmi V, Piovella F, Minzioni G, Viganò M. Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. Eur J Cardiothorac Surg 2000;18:696-701.
16. D'Armini AM, Zanotti G, Viganò M. Pulmonary endarterectomy: the treatment of choice for chronic thromboembolic pulmonary hypertension. Italian Heart J 2005;6:861-868.
17. Corsico AG, D'Armini AM, Cerveri I, Klersy C, Ansaldo E, Niniano R, Gatto E, Monterosso C, Morsolini M, Nicolardi S, Tramontin C, Pozzi E, Viganò M. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 2008;178:419-424.
18. Jamieson SW, Auger WR, Fedullo PR, Channick RN, Kriett JM, Tarazi RY, Moser KM. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993;106:116-127.
19. 2-glycoprotein I antibodies from patients with 2 antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 1998;11:425-429.
20. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-1311.
21. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey DW, Cervera R, Derksen RHWM, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
22. Pierangeli SS, Chen PP, Gonzales EB. Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol 2006;13:366-375.